top of page

News

Imagem1.png

Companies born at ICB-USP work in biosafety, diagnoses and new therapies for cancer.

FAPESP

test4.png

Companies born at ICB-USP work in biosafety, diagnoses and new therapies for cancer.

FAPESP

Imagem do WhatsApp de 2023-05-24 à(s) 14

Companies born at ICB-USP work in biosafety, diagnoses and new therapies for cancer.

FAPESP

Captura de tela 2022-11-09 075549.png

Companies born at ICB-USP work in biosafety, diagnoses and new therapies for cancer.

FAPESP

113.png

Companies born at ICB-USP work in biosafety, diagnoses and new therapies for cancer.

FAPESP

114.png

Companies born at ICB-USP work in biosafety, diagnoses and new therapies for cancer.

FAPESP

fapesp.PNG

Companies born at ICB-USP work in biosafety, diagnoses and new therapies for cancer.

FAPESP

biotechtown.PNG

Biotecntown invests in the 23rd Startup .

Biotechtown

112.png

Companies born at ICB-USP work in biosafety, diagnoses and new therapies for cancer.

FAPESP

sebrae.png

Startup participating in the Sebrae-SP program wins innovation award

sebrae

jornal da usp.PNG

Women scientists undertake to develop cancer immunotherapy.

USP Journal

icb usp.jpg

Startup creator of immunotherapy for cancer wins the Innovative Women Program.

ICB/USP

bottom of page